Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Have Type 2 Diabetes Mellitus~* 18 to 65 years of age~Exclusion Criteria:~* History of Type 1 Diabetes or ketoacidosis~* Have been treated with lipid lowering medications 4 weeks before starting the study~* Have started on a weight loss program and not in the maintenance phase or have started weight loss medication within the last 12 weeks~* Have had surgery in the last 30 days~* History of active liver disease~* History of coronary heart disease or congestive heart failure~* Have had a stroke or transient ischemic neurological disorder in the past 6 months~* Are Human Immunodeficiency Virus (HIV) Positive

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- MK8245 5 mg b.i.d. (Type: EXPERIMENTAL): MK8245
- MK8245 50 mg b.i.d. (Type: EXPERIMENTAL): MK8245
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).